UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 372

Sortiert nach

Pathology of benign prostatic hyperplasia

International journal of impotence research, 2008-12, Vol.20 (S3), p.S11-S18

Roehrborn, C G

2008

Volltextzugriff (PDF)

Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies

BJU international, 2003-08, Vol.92 (3), p.257-261

2003

Volltextzugriff (PDF)

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

International journal of clinical practice (Esher), 2011-04, Vol.65 (4), p.487-507

2011

Volltextzugriff (PDF)

Progression and Remission of Urologic Symptoms in the Community: Results of a Longitudinal Cluster Analysis Approach

Urology (Ridgewood, N.J.), 2014-05, Vol.83 (5), p.1041-1050

2014

Volltextzugriff (PDF)

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients

Urology (Ridgewood, N.J.), 1998-10, Vol.52 (4), p.594-601

1998

Volltextzugriff (PDF)

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

Urology (Ridgewood, N.J.), 1999-03, Vol.53 (3), p.581-589

1999

Volltextzugriff (PDF)

Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia

International journal of impotence research, 2007-10, Vol.19 (5), p.480-485

2007

Volltextzugriff (PDF)

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

Urology (Ridgewood, N.J.), 1996-09, Vol.48 (3), p.398-405

1996

Volltextzugriff (PDF)

Gleason Scores from Prostate Biopsies Obtained with 18-Gauge Biopsy Needles Poorly Predict Gleason Scores of Radical Prostatectomy Specimens

European urology, 1998, Vol.33 (3), p.261-270

1998

Volltextzugriff (PDF)

Proposed cutoff values to define bladder outlet obstruction in women

Urology (Ridgewood, N.J.), 1998-03, Vol.51 (3), p.408-411

1998

Volltextzugriff (PDF)

The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia

International journal of impotence research, 2008-12, Vol.20 (S3), p.S19-S26

Roehrborn, C G

2008

Volltextzugriff (PDF)

OPTIMAL METHOD OF URGENT DECOMPRESSION OF THE COLLECTING SYSTEM FOR OBSTRUCTION AND INFECTION DUE TO URETERAL CALCULI

The Journal of urology, 1998-10, Vol.160 (4), p.1260-1264

1998

Volltextzugriff (PDF)

Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview

Urology, 2001-11, Vol.58 (5), p.642-650

2001

Volltextzugriff (PDF)

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

Urology (Ridgewood, N.J.), 2001-12, Vol.58 (6), p.953-959

Roehrborn, Claus G

2001

Volltextzugriff (PDF)

Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials

Urology (Ridgewood, N.J.), 2001-08, Vol.58 (2), p.210-216

2001

Volltextzugriff (PDF)

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH

Prostate cancer and prostatic diseases, 2011-06, Vol.14 (2), p.143-148

2011

Volltextzugriff (PDF)

Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease

Urology (Ridgewood, N.J.), 2000-08, Vol.56 (2), p.250-254

2000

Volltextzugriff (PDF)

Analysis of Factors Contributing to Success or Failure of 1-Stage Urethroplasty for Urethral Stricture Disease

The Journal of urology, 1994-04, Vol.151 (4), p.869-874

1994

Volltextzugriff (PDF)

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

Prostate cancer and prostatic diseases, 2015-03, Vol.18 (1), p.43-48

2015

Volltextzugriff (PDF)

The potential of serum prostate‐specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia

BJU international, 2004-03, Vol.93 (s1), p.21-26

Roehrborn, C.G.

2004

Volltextzugriff (PDF)

Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications

Prostate cancer and prostatic diseases, 2017-06, Vol.20 (2), p.216-220

2017

Volltextzugriff (PDF)

Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: A meta-analysis and cost-effectiveness analysis

Urology (Ridgewood, N.J.), 1997-05, Vol.49 (5), p.679-686

1997

Volltextzugriff (PDF)

Consensus statement: the role of prostate‐specific antigen in managing the patient with benign prostatic hyperplasia

BJU international, 2004-03, Vol.93 (s1), p.27-29

2004

Volltextzugriff (PDF)

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

The New England journal of medicine, 1998-02, Vol.338 (9), p.557-563

1998

Volltextzugriff (PDF)

Gleason Score Predicts Androgen Independent Progression after Androgen Deprivation Therapy

European urology, 2002-07, Vol.42 (1), p.12-17

2002

Volltextzugriff (PDF)

1 – 25 von 372

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(353)
Mit Volltextzugriff
(241)

Publikationsform

Artikel
(367)
Tagungsberichte
(5)

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(226)
Life Sciences & Biomedicine
(224)
Science & Technology
(224)
Male
(204)
Urology & Nephrology
(200)
Biological And Medical Sciences
(156)
Medical Sciences
(153)
Middle Aged
(143)
Aged
(129)
Nephrology. Urinary Tract Diseases
(91)
Urinary Tract. Prostate Gland
(75)
Tumors Of The Urinary System
(62)
Adult
(59)
Prostate
(54)
Prostatic Hyperplasia - Drug Therapy
(54)
Urology
(51)
Aged, 80 And Over
(48)
Treatment Outcome
(42)
Prostate-Specific Antigen - Blood
(37)
Prostatic Hyperplasia - Complications
(37)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Journal Of Urology
(103)
Urology
(91)
Bju International
(26)
European Urology
(26)
Prostate Cancer And Prostatic Diseases
(22)
Journal Of Urology
(8)
The journal Of Urology/the journal Of Urology
(8)
Reviews In Urology
(7)
World Journal Of Urology
(7)
The Prostate
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Pathology of benign prostatic hyperplasia

Safety and efficacy of alfuzosin 10 mg once‐daily in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a pooled analysis of three double‐blind, placebo‐controlled studies

Antimuscarinics for treatment of storage lower urinary tract symptoms in men: a systematic review

Progression and Remission of Urologic Symptoms in the Community: Results of a Longitudinal Cluster Analysis Approach

Prognostic factors, recurrence, and survival in transitional cell carcinoma of the upper urinary tract: a 30-year experience in 252 patients

Serum prostate-specific antigen as a predictor of prostate volume in men with benign prostatic hyperplasia

Effects of alfuzosin 10 mg once daily on sexual function in men treated for symptomatic benign prostatic hyperplasia

Prostate volume predicts outcome of treatment of benign prostatic hyperplasia with finasteride: Meta-analysis of randomized clinical trials

Gleason Scores from Prostate Biopsies Obtained with 18-Gauge Biopsy Needles Poorly Predict Gleason Scores of Radical Prostatectomy Specimens

Proposed cutoff values to define bladder outlet obstruction in women

The utility of serum prostatic-specific antigen in the management of men with benign prostatic hyperplasia

OPTIMAL METHOD OF URGENT DECOMPRESSION OF THE COLLECTING SYSTEM FOR OBSTRUCTION AND INFECTION DUE TO URETERAL CALCULI

Guidelines for the diagnosis and treatment of benign prostatic hyperplasia: a comparative, international overview

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial

Clinical predictors of spontaneous acute urinary retention in men with LUTS and clinical BPH: a comprehensive analysis of the pooled placebo groups of several large clinical trials

Symptomatic and urodynamic responses in patients with reduced or no seminal emission during silodosin treatment for LUTS and BPH

Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease

Analysis of Factors Contributing to Success or Failure of 1-Stage Urethroplasty for Urethral Stricture Disease

Estrogen receptor beta agonist LY500307 fails to improve symptoms in men with enlarged prostate secondary to benign prostatic hypertrophy

The potential of serum prostate‐specific antigen as a predictor of clinical response in patients with lower urinary tract symptoms and benign prostatic hyperplasia

Formalin disinfection of prostate biopsy needles may reduce post-biopsy infectious complications

Antimicrobial prophylaxis prior to shock wave lithotripsy in patients with sterile urine before treatment: A meta-analysis and cost-effectiveness analysis

Consensus statement: the role of prostate‐specific antigen in managing the patient with benign prostatic hyperplasia

The Effect of Finasteride on the Risk of Acute Urinary Retention and the Need for Surgical Treatment among Men with Benign Prostatic Hyperplasia

Gleason Score Predicts Androgen Independent Progression after Androgen Deprivation Therapy

Suchergebnisse filtern